Colorectal Cancer Screening (COL)

Assesses adults 50–75 who had appropriate screening for colorectal cancer with any of the following tests: annual fecal occult blood test, flexible sigmoidoscopy every 5 years, colonoscopy every 10 years, computed tomography colonography every 5 years, stool DNA test every 3 years.

The Colorectal Cancer Screening measure is also available in an ECDS format. Please visit ECDS webpage and NCQA Store for more information.

Why It Matters

Treatment for colorectal cancer in its earliest stage can lead to a 90 percent survival rate after five years. However, more than a third of adults 50–75 do not get recommended screenings.1 Colorectal cancer screening of asymptomatic adults in that age group can catch polyps before they become cancerous or detect colorectal cancer in its early stages, when treatment is most effective.

Results

Colorectal Cancer Screening Rate

Measure YearCommerical HMOCommercial PPOMedicare HMOMedicare PPO
201965.061.8§§
201864.160.371.175.2
201763.059.369.671.7
201662.058.367.169.8
201562.857.167.466.7
201464.357.766.562.9
201363.356.664.360.8
201263.355.862.158.4
201162.454.660.055.2
201062.647.657.641.0
200960.747.054.940.1
200858.645.353.141.8
200755.642.550.439.5
200654.542.153.347.1
200552.343.454.049.7
200449.0-52.6-

§ Not available due to CMS suspension of data reporting during COVID-19 pandemic.

This State of Healthcare Quality Report classifies health plans differently than NCQA’s Quality Compass. HMO corresponds to All LOBs (excluding PPO and EPO) within Quality Compass. PPO corresponds to PPO and EPO within Quality Compass.

Figures do not account for changes in the underlying measure that could break trending. Contact Information Products via my.ncqa.org for analysis that accounts for trend breaks.

  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.